Skip to main content

Forefront Analytics, LLC

SEC CIK
0001696802
Latest filing
Aug 12, 2026

Holdings changes from Q1 2023 to Q2 2023

Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.

Choose two quarters to compare

New
1
Est. +$93.8K
Added
22
Est. +$6.19M
Reduced
41
Est. −$15.9M
Sold out
15
Est. −$11.1M

Portfolio value went from $194.0M to $175.3M (−$18.7M (−9.6%)); positions from 79 to 65 (−14).

All Q2 2023 holdingsAll Q1 2023 holdings

In the shares, value and % of portfolio columns, the top figure is Q2 2023 and the gray one below is Q1 2023. For stocks that split between the two quarters, Q1 2023 shares are converted at the split ratio before comparing.

Holdings of Forefront Analytics, LLC in Q1 2023 and Q2 2023 compared
SecurityActionSharesShare changeValueEst. bought or sold% of portfolioWeight change (pp)
Nushares ETF Tr67092P300Sold out–0187,045−187,045−100.0%$0$6.37M−$6.37M0.0%3.3%−3.29
IAUiShares Gold TrustSold outHistory046,743−46,743−100.0%$0$1.75M−$1.75M0.0%0.9%−0.90
DBAInvesco DB Agriculture FundSold outHistory040,111−40,111−100.0%$0$819.5K−$819.5K0.0%0.4%−0.42
State Street Energy Select Sector SPDR ETF81369Y506Sold out–06,120−6,120−100.0%$0$506.9K−$506.9K0.0%0.3%−0.26
DBCInvesco DB Commodity Index Tracking FundSold outHistory013,343−13,343−100.0%$0$316.8K−$316.8K0.0%0.2%−0.16
iShares Tr464287234Sold out–07,748−7,748−100.0%$0$305.7K−$305.7K0.0%0.2%−0.16
ABTAbbott LaboratoriesSold outHistory03,009−3,009−100.0%$0$304.7K−$304.7K0.0%0.2%−0.16
iShares Tr464288513Sold out–02,948−2,948−100.0%$0$222.7K−$222.7K0.0%0.1%−0.11
PHGKoninklijke Philips NVSold outHistory010,000−10,000−100.0%$0$183.5K−$183.5K0.0%0.1%−0.09
ORTXOrchard Therapeutics plcSold outHistory014,654−14,654−100.0%$0$78.7K−$78.7K0.0%<0.1%−0.04
ALXOAlx Oncology Holdings IncSold outHistory013,037−13,037−100.0%$0$58.9K−$58.9K0.0%<0.1%−0.03
DMDesktop Metal, Inc.Sold outHistory021,308−21,308−100.0%$0$49.0K−$49.0K0.0%<0.1%−0.03
EIGREiger BioPharmaceuticals, Inc.Sold outHistory051,679−51,679−100.0%$0$46.3K−$46.3K0.0%<0.1%−0.02
SURFSurface Oncology, Inc.Sold outHistory061,156−61,156−100.0%$0$42.7K−$42.7K0.0%<0.1%−0.02
CDAKCodiak BioSciences, Inc.Sold outHistory0110,210−110,210−100.0%$0$19.2K−$19.2K0.0%<0.1%−0.01

Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.